ERS clinical practice guidelines on treatment of sarcoidosis

…, F Martone, B Quadder, G Spitzer… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on which …

Sarcoidosis: patient treatment priorities

…, B Quadder, J Richardson, G Spitzer… - ERJ open …, 2018 - Eur Respiratory Soc
Sarcoidosis is a rare disease with the number of patients in the European Union (28 member
states), Norway, Iceland and Lichtenstein estimated as ∼102 000 [1, 2]. Some 40% of …

[HTML][HTML] New advances in the development of sarcoidosis models: a synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research

…, M Kolb, T Weichhart, WP Drake, G Spitzer… - … Vasculitis, and Diffuse …, 2018 - ncbi.nlm.nih.gov
Sarcoidosis is a complex disease with variable phenotypes that will require a multisystem
approach to understand pathophysiology. One of the most challenging problems in …

Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis.

…, J Grutters, D Valeyre, N Singh, G Spitzer… - … Vasculitis, and Diffuse …, 2023 - europepmc.org
Method patients participated in a six-month prospective study where were asked to wear a
Fitbit OneTM activity tracker daily. device usage education was provided at study enrollment. …

C101 SARCOIDOSIS: The Foundation For Sarcoidosis Research Sarcoidosis Advanced Registry For Cures

L Serchuck, G Spitzer, M Rossman… - American Journal of …, 2016 - search.proquest.com
METHODS: FSR-SARC is a web-based, patient opt-in, observational cohort platform collecting
cross-sectional and longitudinal data via patient self-reports. The item bank includes 87 …

Sarcoidosis treatment and outcomes: what is most important to patients?

…, DI Novel, B Quadder, J Richardson, G Spitzer… - 2018 - Eur Respiratory Soc
Purpose of Study: A sarcoidosis treatment guidleine is being developed by a European
Respiratory Society (ERS) working group. The sarcoidosis support groups were asked to provide …

What is sarcoidosis?

…, M Sockrider, HS Kulkarni, G Spitzer… - American journal of …, 2018 - profiles.wustl.edu
Sarcoidosis (sar-coy-DOE-sis) is a disease of unknown cause in which inflammatory cells
clump together and form tiny lumps of cells in various organs and tissues of the body. These …

To Whom It May Concern, A diagnosis of sarcoidosis can be life changing for patients and their loved ones. As the world's leading nonprofit organization dedicated to …

G Spitzer - stopsarcoidosis.org
Quality of life is often diminished in patients with chronic inflammation associated with
sarcoidosis. Severe complications may include, but are not limited to unmanageable pain …

Volitional change in children with autism: A single-case design study of the impact of hippotherapy on motivation

RR Taylor, G Kielhofner, C Smith, S Butler… - … Therapy in Mental …, 2009 - Taylor & Francis
Autism is a prevalent developmental disorder that affects numerous aspects of a child's
daily functioning, including but not limited to communication, social interaction, cognitive …

Executive summary of the NHLBI workshop report: leveraging current scientific advancements to understand sarcoidosis variability and improve outcomes

LA Maier, ED Crouser, WJ Martin… - Annals of the American …, 2017 - atsjournals.org
Sarcoidosis is a systemic granulomatous disease that primarily affects the lung; it is associated
with significant disparities, more commonly impacting those in the prime of their lives (…